WHO calls for Expressions of Interest in developing Sabin-IPV

Safe and affordable inactivated polio vaccine for low-income countries

The World Health Organization’s Global Polio Eradication Initiative (WHO/POL) is looking for Expressions of Interest from private or public sector vaccine manufacturers in developing countries interested in collaborating with WHO and Intravacc in the development, manufacture and distribution of a safe effective and affordable Sabin Inactivated Polio Vaccine (sIPV), that can be produced securely in developing country settings.

Related


Related News

   24/02/2021
As we approach International Women’s Day, GPEI honours two women without whom we would not be where we are
   13/11/2020
Nouvel outil à utiliser pour lutter contre le PVDVc2
   13/11/2020
WHO has issued an Emergency Use Listing recommendation for the type 2 novel oral polio vaccine (nOPV2)
   07/05/2020
Dr Peter Brauer, a polio survivor and expert on treatment of Post-Polio Syndrome (PPS), illustrates his personal experiences in a moving and beautiful poem.
   29/04/2020
A reminder of why vaccines are so important.
   22/01/2020
Exploring the ‘plus’ in PolioPlus.